Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 78

1.

Genetic analysis of five sedentary fish species in middle Laranjinha River (upper ParanĂ¡ River basin): A case study.

Frantine-Silva W, Ferreira DG, Nascimento RH, Fracasso JF, Conte JE, Ramos FP, Carvalho S, Galindo BA.

Genet Mol Res. 2015 Dec 29;14(4):18637-49. doi: 10.4238/2015.December.28.13.

2.

A pharmacometric pulmonary model predicting the extent and rate of distribution from plasma to epithelial lining fluid and alveolar cells--using rifampicin as an example.

Clewe O, Goutelle S, Conte JE Jr, Simonsson US.

Eur J Clin Pharmacol. 2015 Mar;71(3):313-9. doi: 10.1007/s00228-014-1798-3. Epub 2015 Jan 27.

3.

Mathematical modeling of pulmonary tuberculosis therapy: Insights from a prototype model with rifampin.

Goutelle S, Bourguignon L, Jelliffe RW, Conte JE Jr, Maire P.

J Theor Biol. 2011 Aug 7;282(1):80-92. doi: 10.1016/j.jtbi.2011.05.013. Epub 2011 May 18.

PMID:
21605569
4.

Steady-state intrapulmonary pharmacokinetics and pharmacodynamics of posaconazole in lung transplant recipients.

Conte JE Jr, DeVoe C, Little E, Golden JA.

Antimicrob Agents Chemother. 2010 Sep;54(9):3609-13. doi: 10.1128/AAC.01396-09. Epub 2010 Jun 1.

5.

Intrapulmonary pharmacokinetics and pharmacodynamics of micafungin in adult lung transplant patients.

Walsh TJ, Goutelle S, Jelliffe RW, Golden JA, Little EA, DeVoe C, Mickiene D, Hayes M, Conte JE Jr.

Antimicrob Agents Chemother. 2010 Aug;54(8):3451-9. doi: 10.1128/AAC.01647-09. Epub 2010 May 3.

6.

Population modeling and Monte Carlo simulation study of the pharmacokinetics and antituberculosis pharmacodynamics of rifampin in lungs.

Goutelle S, Bourguignon L, Maire PH, Van Guilder M, Conte JE Jr, Jelliffe RW.

Antimicrob Agents Chemother. 2009 Jul;53(7):2974-81. doi: 10.1128/AAC.01520-08. Epub 2009 Apr 20.

7.

Intrapulmonary pharmacokinetics and pharmacodynamics of posaconazole at steady state in healthy subjects.

Conte JE Jr, Golden JA, Krishna G, McIver M, Little E, Zurlinden E.

Antimicrob Agents Chemother. 2009 Feb;53(2):703-7. doi: 10.1128/AAC.00663-08. Epub 2008 Nov 24.

8.

Intrapulmonary pharmacodynamics of high-dose levofloxacin in subjects with chronic bronchitis or chronic obstructive pulmonary disease.

Conte JE Jr, Golden JA, McIver M, Little E, Zurlinden E.

Int J Antimicrob Agents. 2007 Nov;30(5):422-7. Epub 2007 Aug 22.

PMID:
17716873
9.

Intrapulmonary pharmacokinetics and pharmacodynamics of high-dose levofloxacin in healthy volunteer subjects.

Conte JE Jr, Golden JA, McIver M, Zurlinden E.

Int J Antimicrob Agents. 2006 Aug;28(2):114-21. Epub 2006 Jul 11.

PMID:
16837169
10.

Intrapulmonary pharmacokinetics and pharmacodynamics of meropenem.

Conte JE Jr, Golden JA, Kelley MG, Zurlinden E.

Int J Antimicrob Agents. 2005 Dec;26(6):449-56. Epub 2005 Nov 8.

PMID:
16280244
11.

Steady-state serum and intrapulmonary pharmacokinetics and pharmacodynamics of tigecycline.

Conte JE Jr, Golden JA, Kelly MG, Zurlinden E.

Int J Antimicrob Agents. 2005 Jun;25(6):523-9.

PMID:
15885987
12.

Intrapulmonary pharmacokinetics and pharmacodynamics of itraconazole and 14-hydroxyitraconazole at steady state.

Conte JE Jr, Golden JA, Kipps J, McIver M, Zurlinden E.

Antimicrob Agents Chemother. 2004 Oct;48(10):3823-7.

13.

Steady-state plasma and intrapulmonary pharmacokinetics and pharmacodynamics of cethromycin.

Conte JE Jr, Golden JA, Kipps J, Zurlinden E.

Antimicrob Agents Chemother. 2004 Sep;48(9):3508-15.

14.

Bone wax as a risk factor for surgical-site infection following neurospinal surgery.

Gibbs L, Kakis A, Weinstein P, Conte JE Jr.

Infect Control Hosp Epidemiol. 2004 Apr;25(4):346-8.

PMID:
15108734
15.

Effect of sex and AIDS status on the plasma and intrapulmonary pharmacokinetics of rifampicin.

Conte JE, Golden JA, Kipps JE, Lin ET, Zurlinden E.

Clin Pharmacokinet. 2004;43(6):395-404.

PMID:
15086276
17.

An outbreak of group A Streptococcal infection among health care workers.

Kakis A, Gibbs L, Eguia J, Kimura J, Vogelei D, Troup N, Stevens D, Kaplan EL, Johnson DR, Conte JE Jr.

Clin Infect Dis. 2002 Dec 1;35(11):1353-9. Epub 2002 Nov 11.

PMID:
12439798
18.

Effects of gender, AIDS, and acetylator status on intrapulmonary concentrations of isoniazid.

Conte JE Jr, Golden JA, McQuitty M, Kipps J, Duncan S, McKenna E, Zurlinden E.

Antimicrob Agents Chemother. 2002 Aug;46(8):2358-64. Erratum in: Antimicrob Agents Chemother. 2002 Sep;46(9):3112..

19.

Intrapulmonary pharmacokinetics of linezolid.

Conte JE Jr, Golden JA, Kipps J, Zurlinden E.

Antimicrob Agents Chemother. 2002 May;46(5):1475-80.

21.

Effects of AIDS and gender on steady-state plasma and intrapulmonary ethambutol concentrations.

Conte JE Jr, Golden JA, Kipps J, Lin ET, Zurlinden E.

Antimicrob Agents Chemother. 2001 Oct;45(10):2891-6.

22.

Surgical-wound infection with Pasteurella multocida from pet dogs.

Octavio J, Rosenberg W, Conte JE Jr.

N Engl J Med. 2001 Aug 16;345(7):549. No abstract available.

PMID:
11519523
23.
24.

Effects of AIDS and gender on steady-state plasma and intrapulmonary ethionamide concentrations.

Conte JE Jr, Golden JA, McQuitty M, Kipps J, Lin ET, Zurlinden E.

Antimicrob Agents Chemother. 2000 May;44(5):1337-41.

25.

Single-dose intrapulmonary pharmacokinetics of rifapentine in normal subjects.

Conte JE Jr, Golden JA, McQuitty M, Kipps J, Lin ET, Zurlinden E.

Antimicrob Agents Chemother. 2000 Apr;44(4):985-90.

26.
27.
28.

Intrapulmonary concentrations of pyrazinamide.

Conte JE Jr, Golden JA, Duncan S, McKenna E, Zurlinden E.

Antimicrob Agents Chemother. 1999 Jun;43(6):1329-33.

29.
30.

A novel approach to preventing insect-borne diseases.

Conte JE Jr.

N Engl J Med. 1997 Sep 11;337(11):785-6. No abstract available.

PMID:
9287238
31.

Effect of charcoal hemoperfusion on clearance of pentamidine isethionate after accidental overdose.

Watts RG, Conte JE Jr, Zurlinden E, Waldo FB.

J Toxicol Clin Toxicol. 1997;35(1):89-92.

PMID:
9022658
32.

Single-dose intrapulmonary pharmacokinetics of azithromycin, clarithromycin, ciprofloxacin, and cefuroxime in volunteer subjects.

Conte JE Jr, Golden J, Duncan S, McKenna E, Lin E, Zurlinden E.

Antimicrob Agents Chemother. 1996 Jul;40(7):1617-22.

34.

Intrapulmonary pharmacokinetics of clarithromycin and of erythromycin.

Conte JE Jr, Golden JA, Duncan S, McKenna E, Zurlinden E.

Antimicrob Agents Chemother. 1995 Feb;39(2):334-8.

35.

Pharmacokinetics of cefodizime in volunteers with normal or impaired renal function.

Conte JE Jr.

J Clin Pharmacol. 1994 Nov;34(11):1066-70.

PMID:
7876397
36.

A randomized comparison of once-monthly or twice-monthly high-dose aerosolized pentamidine prophylaxis.

Golden JA, Katz MH, Chernoff DN, Duncan SM, Conte JE Jr.

Chest. 1993 Sep;104(3):743-50.

PMID:
8365284
37.

Evaluation of new anti-infective drugs for surgical prophylaxis. Infectious Diseases Society of America and the Food and Drug Administration.

Gorbach SL, Condon RE, Conte JE Jr, Kaiser AB, Ledger WJ, Nichols RL.

Clin Infect Dis. 1992 Nov;15 Suppl 1:S313-38.

PMID:
1477247
38.
39.

Intravenous or inhaled pentamidine for treating Pneumocystis carinii pneumonia in AIDS. A randomized trial.

Conte JE Jr, Chernoff D, Feigal DW Jr, Joseph P, McDonald C, Golden JA.

Ann Intern Med. 1990 Aug 1;113(3):203-9.

PMID:
2197911
40.

Pentamidine-induced pancreatic beta-cell dysfunction.

Shen M, Orwoll ES, Conte JE Jr, Prince MJ.

Am J Med. 1989 Jun;86(6 Pt 1):726-8. No abstract available.

PMID:
2658578
41.

Prevention of Pneumocystis carinii pneumonia by inhaled pentamidine.

Golden JA, Chernoff D, Hollander H, Feigal D, Conte JE.

Lancet. 1989 Mar 25;1(8639):654-7.

PMID:
2564468
42.

Travelers' diarrhea.

Conte JE.

West J Med. 1989 Jan;150(1):67. No abstract available.

43.

Antibiotic prophylaxis: non-abdominal surgery.

Conte JE Jr.

Curr Clin Top Infect Dis. 1989;10:254-305. Review. No abstract available.

PMID:
2679696
44.
45.

Non-O:1 Vibrio cholerae bacteremia: case report and review.

Safrin S, Morris JG Jr, Adams M, Pons V, Jacobs R, Conte JE Jr.

Rev Infect Dis. 1988 Sep-Oct;10(5):1012-7. Review.

PMID:
3055182
46.

Pentamidine pharmacokinetics in patients with AIDS with impaired renal function.

Conte JE Jr, Upton RA, Lin ET.

J Infect Dis. 1987 Dec;156(6):885-90.

PMID:
3680992
47.

Inhaled or reduced-dose intravenous pentamidine for Pneumocystis carinii pneumonia. A pilot study.

Conte JE Jr, Hollander H, Golden JA.

Ann Intern Med. 1987 Oct;107(4):495-8.

PMID:
3498418
48.

Pharmacokinetics of cefpiramide in volunteers with normal or impaired renal function.

Conte JE Jr.

Antimicrob Agents Chemother. 1987 Oct;31(10):1585-8.

49.

Column liquid chromatographic determination of cefpiramide in human serum and urine.

Conte JE Jr, Zurlinden E.

J Chromatogr. 1987 Jul 3;417(2):452-7. No abstract available.

PMID:
3654896
50.

Ceftriaxone treatment of multidrug-resistant Salmonella osteomyelitis.

Sherman JW, Conte JE Jr.

Am J Med. 1987 Jul;83(1):137-8.

PMID:
3605165

Supplemental Content

Loading ...
Support Center